Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion type Assertion NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_head.
- NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion description "[The clinical relevance could include the use of locally administered HGF/SF in protein or gene form to minimize formation of keloids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_provenance.
- NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion evidence source_evidence_literature NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_provenance.
- NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion SIO_000772 18087663 NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_provenance.
- NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion wasDerivedFrom befree-20140225 NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_provenance.
- NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_assertion wasGeneratedBy ECO_0000203 NP624955.RA809LYXwAT4nWKLEkIBsmFFXiH0d2N1n0qU-M7SURq90130_provenance.